Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bruno

Showing results (351-360 of 355) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 355 results.
Biorxiv : the Preprint Server for Biology|February 20, 2025
<i>CDKN2A</i> <sup>Low</sup> cancer cells outcompete macrophages for microenvironmental zinc to drive immunotherapy resistanceRaquel Buj, Aidan R Cole, Jeff Danielson, et al.
Journal for Immunotherapy of Cancer|March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocolsTricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
The Journal of Clinical Investigation|December 24, 2024
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer modelsDezhi Li, Ke Geng, Yuan Hao, et al.
Journal of Hematology & Oncology|January 13, 2025
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transitionAntonino Glaviano, Hannah Si-Hui Lau, Lukas M Carter, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancerRaphaël Mattiuz, Jesse Boumelha, Pauline Hamon, et al.
Pageof 36

Showing results (351-360 of 355) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 355 results.
Biorxiv : the Preprint Server for Biology|February 20, 2025
<i>CDKN2A</i> <sup>Low</sup> cancer cells outcompete macrophages for microenvironmental zinc to drive immunotherapy resistanceRaquel Buj, Aidan R Cole, Jeff Danielson, et al.
Journal for Immunotherapy of Cancer|March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocolsTricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
The Journal of Clinical Investigation|December 24, 2024
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer modelsDezhi Li, Ke Geng, Yuan Hao, et al.
Journal of Hematology & Oncology|January 13, 2025
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transitionAntonino Glaviano, Hannah Si-Hui Lau, Lukas M Carter, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancerRaphaël Mattiuz, Jesse Boumelha, Pauline Hamon, et al.
Pageof 36